Investor relations

Investor relations

Investor Day

18th November 2014, London

AstraZeneca hosted an Investor Day for institutional investors and financial analysts held on Tuesday 18th November 2014. Presentations were made from Pascal Soriot and his management team that provided an updated view of AstraZeneca’s strategy and plans to return to growth and scientific leadership in our chosen areas.

View event details


Latest downloads

AstraZeneca Investor Day

18 November 2014

Third quarter and nine months results 2014

6 November 2014

European Society for Medical Oncology (ESMO) 2014

28 September 2014

Second quarter and half year results 2014

31 July 2014


Annual Report 2013

AstraZeneca Annual Report 2013

Our Annual Report provides a wide range of information about our global business and how we are working, both within the company and in partnership with others, to push the boundaries of science and deliver medicines that transform the lives of people around the world.


Currency guidance 2014

In order to help analysts and investors estimate the impact of changing exchange rates on sales and earnings, the Company provides an annual 'currency sensitivity guide', alongside the rates upon which its earnings guidance is based.

The latest guide, intended to help estimate the impact of currency movements for 2014, is an update of the 2013 guidance given in January 2013.

View 2014 currency guidance


Keeping investors in touch

Download our iPad app now from the app store

AstraZeneca Investor Relations iPad app

The AstraZeneca Investor Relations iPad app provides instant access to our latest news, webcasts and presentations, events and leadership videos.

Notifications will keep you up to date with the most recent updates from AstraZeneca and synchronise to your device for reference.

Download and install from the iTunes store


Share price

London
46.60 GBP
New York
73.91 USD
Stockholm
544.00 SEK

At 27-11-2014 05:19 GMT

Detailed share price


Stock symbol - AZN

On LSE, NYE and OMX